DOJ reportedly to sue Visa over debit card monopoly

The guest is the CEO of Novo Nordisk, a leading pharmaceutical company known for its innovations in diabetes care. They dive into the U.S. DOJ's impending antitrust lawsuit against Visa, detailing its implications for the debit card market. The discussion also touches on Dannon's surprising acquisition move for Lifeway Foods, which has sent stock prices soaring, and the ongoing struggles at Boeing as the union remains divided over a contract offer. Insights into these market shifts reveal the interconnectedness of industries and the influence of regulatory actions.